Praneeth Reddy Kuninty

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jai Prakash · 5 shared papers, 2017–2026 · strength 0.83
   • Paper Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in p… DOI 10.1016/j.apsb.2025.10.022↗
   • Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1↗
   • Paper Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. DOI 10.1016/j.canlet.2018.01.072↗
2. Deby Fajar Mardhian · 2 shared papers, 2019–2026 · strength 0.38
   • Paper Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in p… DOI 10.1016/j.apsb.2025.10.022↗
   • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
3. Kunal P. Pednekar · 1 shared paper, 2026 · strength 0.30
   • Paper Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in p… DOI 10.1016/j.apsb.2025.10.022↗
4. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.30
   • Paper Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in p… DOI 10.1016/j.apsb.2025.10.022↗
5. Miles Aaron Miller · 1 shared paper, 2026 · strength 0.29
   • Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1↗
6. David Lagares · 1 shared paper, 2026 · strength 0.29
   • Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1↗
7. Ahmed M. R. H. Mostafa · 1 shared paper, 2026 · strength 0.29
   • Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1↗
8. Jonas Schnittert · 3 shared papers, 2017–2019 · strength 0.24
   • Paper Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. DOI 10.1016/j.canlet.2018.01.072↗
   • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
   • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
9. Arne Östman · 2 shared papers, 2017–2019 · strength 0.14
   • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
   • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
10. Susanna W.L. de Geus · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
11. Peter J.K. Kuppen · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
12. Cornelis F.M. Sier · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
13. Hanneke W.M. van Laarhoven · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
14. Alexander L. Vahrmeijer · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
15. Maarten F. Bijlsma · 1 shared paper, 2019 · strength 0.08
    • Paper ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancre… DOI 10.1126/sciadv.aax2770↗
16. Carlos Fernández Moro · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
17. Dan Calatayud · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
18. Rainer Lothar Heuchel · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
19. Nicolai A. Schultz · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
20. Carina Strell · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
21. Artur Mezheyeuski · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
22. Julia Sidenius Johansen · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
23. Matthias J. Löhr · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
24. Caroline Sophie Verbeke · 1 shared paper, 2017 · strength 0.06
    • Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.